Deng L - Search Results

1

Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma.

Tang J, Jiang R, Deng L, Zhang X, Wang K, Sun B. Tang J, et al. Among authors: deng l. Oncotarget. 2015 Feb 28;6(6):4505-15. doi: 10.18632/oncotarget.2934. Oncotarget. 2015. PMID: 25714016 Free PMC article.

2

The level of oncogene H-Ras correlates with tumorigenicity and malignancy.

Sun B, Gao Y, Deng L, Li G, Cheng F, Wang X. Sun B, et al. Among authors: deng l. Cell Cycle. 2008 Apr 1;7(7):934-9. doi: 10.4161/cc.7.7.5622. Epub 2008 Jan 17. Cell Cycle. 2008. PMID: 18414051

3

High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.

Jiang R, Xia Y, Li J, Deng L, Zhao L, Shi J, Wang X, Sun B. Jiang R, et al. Among authors: deng l. Int J Cancer. 2010 Mar 1;126(5):1263-74. doi: 10.1002/ijc.24854. Int J Cancer. 2010. PMID: 19728335

4

Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA.

Deng L, Li G, Xi L, Yin A, Gao Y, You W, Wang X, Sun B. Deng L, et al. BMC Gastroenterol. 2009 Oct 6;9:73. doi: 10.1186/1471-230X-9-73. BMC Gastroenterol. 2009. PMID: 19804649 Free PMC article.

5

[Inhibitory effect of lentivirus transduced anti-telomerase siRNA therapy on hepatocellular carcinoma in nude mice].

Zhang Y, Gao Y, Xi LS, Deng L, Yin AH, Wang XH, Sun BC. Zhang Y, et al. Among authors: deng l. Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):410-3. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950547 Chinese.

6

Hydrodynamics-based transfection of plasmid encoding receptor activator for nuclear factor kappa B-Fc protects against hepatic ischemia/reperfusion injury in mice.

Shi J, Shao W, Yang D, Zhao L, Deng L, Wang X, Sun B. Shi J, et al. Among authors: deng l. Liver Transpl. 2010 May;16(5):611-20. doi: 10.1002/lt.22030. Liver Transpl. 2010. PMID: 20440770 Free article.

7

Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma.

Li G, Wu X, Zhang F, Li X, Sun B, Yu Y, Yin A, Deng L, Yin J, Wang X. Li G, et al. Among authors: deng l. J Cancer Res Clin Oncol. 2011 Apr;137(4):695-703. doi: 10.1007/s00432-010-0905-9. Epub 2010 Jun 19. J Cancer Res Clin Oncol. 2011. PMID: 20563597

8

Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.

Jiang R, Tan Z, Deng L, Chen Y, Xia Y, Gao Y, Wang X, Sun B. Jiang R, et al. Among authors: deng l. Hepatology. 2011 Sep 2;54(3):900-9. doi: 10.1002/hep.24486. Epub 2011 Aug 8. Hepatology. 2011. PMID: 21674558

9

miR-22 promotes HBV-related hepatocellular carcinoma development in males.

Jiang R, Deng L, Zhao L, Li X, Zhang F, Xia Y, Gao Y, Wang X, Sun B. Jiang R, et al. Among authors: deng l. Clin Cancer Res. 2011 Sep 1;17(17):5593-603. doi: 10.1158/1078-0432.CCR-10-1734. Epub 2011 Jul 12. Clin Cancer Res. 2011. PMID: 21750200

10

Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.

Hou J, Xu J, Jiang R, Wang Y, Chen C, Deng L, Huang X, Wang X, Sun B. Hou J, et al. Among authors: deng l. Hepatology. 2013 Feb;57(2):678-88. doi: 10.1002/hep.25980. Epub 2012 Oct 30. Hepatology. 2013. PMID: 22821478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,771 results

Search Page

Filters